Cargando…

An Anti-Checkpoint Activity for Rif1

Detalles Bibliográficos
Autores principales:	Harari, Yaniv, Rubinstein, Linda, Kupiec, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240591/ https://www.ncbi.nlm.nih.gov/pubmed/22194704 http://dx.doi.org/10.1371/journal.pgen.1002421

Ejemplares similares

Genome-wide studies of telomere biology in budding yeast
por: Harari, Yaniv, et al.
Publicado: (2014)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

Long Telomeres Do Not Affect Cellular Fitness in Yeast
por: Harari, Yaniv, et al.
Publicado: (2017)

Telomere length kinetics assay (TELKA) sorts the telomere length maintenance (tlm) mutants into functional groups
por: Rubinstein, Linda, et al.
Publicado: (2014)

The role of Holliday junction resolvases in the repair of spontaneous and induced DNA damage
por: Agmon, Neta, et al.
Publicado: (2011)

A Novel Checkpoint and RPA Inhibitory Pathway Regulated by Rif1
por: Xue, Yuan, et al.
Publicado: (2011)

Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
por: Tan, Shuguang, et al.
Publicado: (2016)

Environmental Stresses Disrupt Telomere Length Homeostasis
por: Romano, Gal Hagit, et al.
Publicado: (2013)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

Hallmarks of Resistance to Immune-Checkpoint Inhibitors
por: Karasarides, Maria, et al.
Publicado: (2022)

Mck1 kinase is a new player in the DNA damage checkpoint pathway
por: Sanvisens Delgado, Nerea, et al.
Publicado: (2019)

Role of the ESCRT Complexes in Telomere Biology
por: Dieckmann, Anna K., et al.
Publicado: (2016)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

A vision for ubiquitous sequencing
por: Erlich, Yaniv
Publicado: (2015)

Immune checkpoint molecules: “new” kids on the block of skin photoimmunology
por: Wang, Wei, et al.
Publicado: (2019)

The future of immune checkpoint combinations with tumor-targeted small molecule drugs
por: Sceneay, Jaclyn, et al.
Publicado: (2021)

The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected Wounds
por: Franzini, Marianno, et al.
Publicado: (2023)

When genes move, genomes collide
por: Brandvain, Yaniv, et al.
Publicado: (2018)

Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy
por: Novotny, J. F., et al.
Publicado: (2016)

The Yeast PCNA Unloader Elg1 RFC-Like Complex Plays a Role in Eliciting the DNA Damage Checkpoint
por: Sau, Soumitra, et al.
Publicado: (2019)

CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data
por: Zujewski, Jo Anne, et al.
Publicado: (2017)

Checkpoint phosphorylation sites on budding yeast Rif1 protect nascent DNA from degradation by Sgs1-Dna2
por: Gali, Vamsi Krishna, et al.
Publicado: (2023)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
por: Sarkis, J., et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities
por: Rizzo, Alessandro
Publicado: (2022)

Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research
por: Cheung, Yee-Ming M, et al.
Publicado: (2023)

Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
por: Tsuji, Ai, et al.
Publicado: (2023)

LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities
por: Santos, Jaime, et al.
Publicado: (2022)

Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics
por: Steinman, Jonathan Baruch, et al.
Publicado: (2020)

Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later?
por: Olivier, Timothée, et al.
Publicado: (2022)

Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing
por: Evans, Ronald M., et al.
Publicado: (2020)

4-1BB Agonism as a strategy to license immune checkpoint blockade in glioblastoma
por: Woroniecka, Karolina, et al.
Publicado: (2020)

Checkpoint blockade therapy for functioning pituitary adenomas
por: Lorrey, Selena J., et al.
Publicado: (2020)

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
por: Lipsitch, Marc, et al.
Publicado: (2021)

Rif1-Dependent Control of Replication Timing
por: Richards, Logan, et al.
Publicado: (2022)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

Metabolic checkpoints in neurodegenerative T helper 17 (T(H)17) and neuroregenerative regulatory T (T(reg)) cells as new therapeutic targets for multiple sclerosis
por: Shen, Hongxing, et al.
Publicado: (2019)

Anti-Interferon Auto-Antibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Levin, Michael
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4bibkm14mffhn9cb0ukq4l8g2b